Complete response with sorafenib and transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Complete response with sorafenib and transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 22, Issue 42, Pages 9445
Publisher
Baishideng Publishing Group Inc.
Online
2016-11-12
DOI
10.3748/wjg.v22.i42.9445
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion
- (2016) Takashi Kokudo et al. JOURNAL OF HEPATOLOGY
- Surgical Strategy for Hepatocellular Carcinoma Patients with Portal/Hepatic Vein Tumor Thrombosis
- (2015) Li Shaohua et al. PLoS One
- Portal vein thrombosis in cirrhosis: Controversies and latest developments
- (2015) Damian J Harding et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Long-term complete response of advanced hepatocellular carcinoma treated with multidisciplinary therapy including reduced dose of sorafenib: case report and review of the literature
- (2015) Masahiro Shinoda et al. World Journal of Surgical Oncology
- Serial changes of clinical parameters in a patient with advanced hepatocellular carcinoma with portal vein thrombosis achieving complete response after treatment with sorafenib
- (2014) Sheng-Nan Lu et al. OncoTargets and Therapy
- The effect of alkaline phosphatase and intrahepatic metastases in large hepatocellular carcinoma
- (2013) Jong Man Kim et al. World Journal of Surgical Oncology
- Sustained complete response of hepatocellular carcinoma with portal vein tumor thrombus following discontinuation of sorafenib: A case report
- (2013) KAZUE SHIOZAWA et al. Oncology Letters
- Hepatocellular carcinoma
- (2012) Alejandro Forner et al. LANCET
- Complete response for advanced liver cancer during sorafenib therapy: Case Report
- (2011) Rodolfo Sacco et al. BMC GASTROENTEROLOGY
- Complete regression of locally advanced hepatocellular carcinoma induced by sorafenib allowing curative resection
- (2011) Sabine Irtan et al. LIVER INTERNATIONAL
- AFP Measurement in Monitoring Treatment Response of Advanced Hepatocellular Carcinoma to Sorafenib: Case Report and Review of the Literature
- (2011) Thomas Gamstätter et al. ONKOLOGIE
- Transarterial Chemoembolization Can Be Safely Performed in Patients with Hepatocellular Carcinoma Invading the Main Portal Vein and May Improve the Overall Survival
- (2011) Goh Eun Chung et al. RADIOLOGY
- Optimized management of advanced hepatocellular carcinoma: Four long-lasting responses to sorafenib
- (2011) Giovanni Abbadessa WORLD JOURNAL OF GASTROENTEROLOGY
- Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Prospective Comparative Study
- (2010) Jun Luo et al. ANNALS OF SURGICAL ONCOLOGY
- Complete remission of unresectable hepatocellular carcinoma treated with reduced dose of sorafenib: a case report
- (2010) Sean Xiang Wang et al. Targeted Oncology
- Transcatheter arterial chemoembolization vs. chemoinfusion for unresectable hepatocellular carcinoma in patients with major portal vein thrombosis
- (2009) J. H. KIM et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now